Parkinson’s Disease & ADHD
Are the two related?
Does ADHD medication increase your risk?
A recent study from July 2018, published in The Michael J. Fox Foundation Fox Feed Blog conducted by Parkinson’s Foundation found that the prevalence of Parkinson’s disease is increasing. By 2030, it’s estimated that 1.2 million Americans will be living with the disease.
Current research conducted by the University of Utah Health shows that there is a correlation between ADHD and Parkinson’s Disease.
“Parkinson’s disease is commonly thought of as a neurodegenerative disease associated with aging,” said Glen Hanson, D.D.S., Ph.D., professor of Pharmacology and Toxicology and School of Dentistry at U of U Health and senior author on the paper. “This may be the first time where a childhood disease and its treatment may be linked to a geriatric expression of neurodegenerative disorder.”
Hanson’s team has found that individuals with ADHD are at an increased risk for Parkinson’s Disease as well as other similar disorders. Their research posted in Science Daily shows that individuals are twice as likely to develop early onset (21-66 years old) Parkinson’s and Parkinson’s like disease compared to nonADHD individuals of the same age and gender. Additionally, their research found that individuals on prescribed stimulant medications, including methylphenidate (Ritalin, Concerta, Daytrana, Metadate andMethylin), mixed amphetamine salts (Adderall) and dexmethylphenidate (Focalin) are at an even higher risk (6 to 8 times higher) than an ADHD individual not on medication. This is a staggering number and researchers are still trying to determine the exact pin point of the increased numbers and their correlation with the medication.